Clinical trial

Observational Study to Assess the Efficacy and Safety of NovoRapid™ Flexpen™

NCT00675220

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention insulin aspart Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Observational Study to Assess the Efficacy and Safety of NovoRapid™ Flexpen™

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2007-06-01

PhaseN/A

Conditions

Diabetesverified · MONDO: diabetes mellitus

Diabetes Mellitus, Type 1candidate · MONDO: type 1 diabetes mellitus

Diabetes Mellitus, Type 2verified · MONDO: type 2 diabetes mellitus

Delivery Systemsunresolved

Interventions

insulin aspartDRUG

Sponsors & collaborators

Novo Nordisk A/Slead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00675220 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.